ES2191977T3 - Soluciones y dispersiones en estado solido de farmacos poco solubles en agua. - Google Patents
Soluciones y dispersiones en estado solido de farmacos poco solubles en agua.Info
- Publication number
- ES2191977T3 ES2191977T3 ES98955458T ES98955458T ES2191977T3 ES 2191977 T3 ES2191977 T3 ES 2191977T3 ES 98955458 T ES98955458 T ES 98955458T ES 98955458 T ES98955458 T ES 98955458T ES 2191977 T3 ES2191977 T3 ES 2191977T3
- Authority
- ES
- Spain
- Prior art keywords
- water
- pharmacos
- solubles
- dispersions
- little
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención describe una composición útil como excipiente farmacéutico, el procedimiento de producción del mismo y las composiciones farmacéuticas producidas de esta manera. En particular, la invención se aplica para mejorar la solubilidad de los compuestos terapéuticamente activos ligeramente solubles en agua, por medio de un excipiente que comprende una mezcla de : (a) glicéridos poliglicolizados saturados y (b) copolímeros secuenciados polioxipropileno - polioxietileno, en la que se mejora la solubilidad del compuesto terapéuticamente activo poco soluble en la composición farmacéutica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6333897P | 1997-10-27 | 1997-10-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2191977T3 true ES2191977T3 (es) | 2003-09-16 |
Family
ID=22048528
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98955458T Expired - Lifetime ES2191977T3 (es) | 1997-10-27 | 1998-10-15 | Soluciones y dispersiones en estado solido de farmacos poco solubles en agua. |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0996429B1 (es) |
JP (1) | JP2001520984A (es) |
CN (1) | CN1190187C (es) |
AT (1) | ATE232087T1 (es) |
DE (1) | DE69811233T2 (es) |
DK (1) | DK0996429T3 (es) |
ES (1) | ES2191977T3 (es) |
NO (1) | NO329755B1 (es) |
PT (1) | PT996429E (es) |
WO (1) | WO1999021534A1 (es) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2775597B1 (fr) * | 1998-03-04 | 2001-04-20 | Gattefosse Ets Sa | Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication |
NZ508645A (en) * | 1998-06-05 | 2003-10-31 | Forbes Medi Tech Inc | Compositions comprising phytosterol and/or phytostanol having enhanced solubility and dispersability and the use of these compositions to lower serum cholesterol |
US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
SE9901667D0 (sv) * | 1999-05-07 | 1999-05-07 | Astra Ab | Method and device for forming particles |
SE9902742D0 (sv) * | 1999-07-20 | 1999-07-20 | Astra Ab | New pharmaceutical formultion |
US20010036479A1 (en) * | 2000-01-14 | 2001-11-01 | Gillian Cave | Glyburide composition |
ITMI20011337A1 (it) * | 2001-06-26 | 2002-12-26 | Farmatron Ltd | Composizioni farmaceutiche orali a rilascio modificato del principio attivo |
ITMI20011338A1 (it) * | 2001-06-26 | 2002-12-26 | Farmatron Ltd | Composizioni farmaceutiche orali a rilascio immediato del principio attivo |
RU2330642C2 (ru) * | 2001-07-06 | 2008-08-10 | Лайфсайкл Фарма А/С | Регулируемая агломерация |
IS6633A (is) * | 2002-11-22 | 2004-05-23 | Omega Farma Ehf. | Samsetningar af fínasteríð töflum |
JP2006511525A (ja) * | 2002-12-13 | 2006-04-06 | ヤゴテック アーゲー | ナノ粒子状スピロノラクトン局所製剤 |
AU2004212976A1 (en) * | 2003-02-19 | 2004-09-02 | Biovail Laboratories Inc. | Rapid absorption selective 5-HT agonist formulations |
KR101105486B1 (ko) | 2003-04-02 | 2012-01-13 | 아레스 트레이딩 에스.에이. | Fsh 및 lh과 비이온성 계면활성제의 액상 약제학적 제제 |
JP4871124B2 (ja) | 2003-06-20 | 2012-02-08 | アレス トレーディング ソシエテ アノニム | 凍結乾燥fsh/lh製剤 |
AU2004291080A1 (en) * | 2003-11-13 | 2005-06-02 | Alza Corporation | Melt blend dispersions comprising a low water solubility drug and an ethylene oxide-propylene oxide block copolymer |
WO2005065657A2 (en) | 2003-12-31 | 2005-07-21 | Pfizer Products Inc. | Solid compositions of low-solubility drugs and poloxamers |
TW200616681A (en) * | 2004-10-05 | 2006-06-01 | Recordati Ireland Ltd | Lercanidipine capsules |
AU2005305880B2 (en) * | 2004-11-17 | 2010-08-26 | Ares Trading S.A. | Benzothiazole formulations and use thereof |
EP1690528A1 (de) * | 2005-02-11 | 2006-08-16 | Abbott GmbH & Co. KG | Herstellung von Dosierungsformen mit einer festen Dispersion eines mikrokristallinen Wirkstoffs |
ES2277767B1 (es) * | 2005-11-04 | 2008-04-01 | Simbec Iberica, S.L. | Formas orales solidas de ebastina. |
EP1962808B1 (en) * | 2005-12-14 | 2010-09-29 | F. Hoffmann-La Roche AG | Hcv prodrug formulation |
KR101462693B1 (ko) * | 2006-08-16 | 2014-11-17 | 노파르티스 아게 | 고도 결정질 치료용 화합물의 고체 분산체 제조 방법 |
EP1972336A1 (en) * | 2007-03-19 | 2008-09-24 | LEK Pharmaceuticals D.D. | Hot-melt micropellets |
WO2010143199A1 (en) * | 2009-06-11 | 2010-12-16 | Suven Nishtaa Pharma Private Limited | Solid lipid dispersion for aqueous solubility enhancement of poorly water soluble drugs |
US20120322752A1 (en) * | 2009-12-08 | 2012-12-20 | Sung Kyun Lee | SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL |
US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US8895537B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating cardiovascular diseases |
US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
SG10201508982TA (en) * | 2010-11-01 | 2015-12-30 | Melinta Therapeutics Inc | Pharmaceutical compositions |
EP2455068A1 (en) * | 2010-11-09 | 2012-05-23 | F. Hoffmann-La Roche AG | Pharmaceutical composition for treating HCV infections |
EP2844223A1 (en) * | 2012-05-03 | 2015-03-11 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
DE102012105512A1 (de) * | 2012-06-25 | 2014-04-24 | Hennig Arzneimittel Gmbh & Co. Kg | Arzneiform zur verlängerten Freisetzung von Wirkstoffen |
WO2014176389A1 (en) | 2013-04-24 | 2014-10-30 | Temple University - Of The Commonwealth System Of Higher Education | Solid dosage form containing arabinogalactan |
US20160151503A1 (en) * | 2013-08-01 | 2016-06-02 | Mw Encap Limited | Compositions and preparation methods of low melting ionic salts of poorly-water soluble drugs |
WO2016162229A1 (en) | 2015-04-10 | 2016-10-13 | Capsugel Belgium N.V. | Abiraterone acetate lipid formulations |
EP3492070A1 (en) * | 2017-11-30 | 2019-06-05 | BIT Pharma GmbH | Process and device for preparing a solid dispersion |
EP3883548A4 (en) * | 2019-04-08 | 2022-11-09 | Cosci Med-tech Co. Ltd. | METHODS FOR IMPROVING THE SOLUBILIZATION OF PHARMACEUTICAL SUBSTANCES AND PRODUCTS THEREOF |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8524421D0 (en) * | 1985-10-03 | 1985-11-06 | Boots Co Plc | Therapeutic agents |
JPS62120315A (ja) * | 1985-11-20 | 1987-06-01 | Shin Etsu Chem Co Ltd | 経口投与型徐放性錠剤の製造方法 |
JPH05255125A (ja) * | 1992-02-29 | 1993-10-05 | Upjohn Co:The | 徐放性製剤およびその製法 |
JPH06316517A (ja) * | 1993-02-22 | 1994-11-15 | Grelan Pharmaceut Co Ltd | 放出制御製剤 |
US5487887A (en) * | 1993-10-28 | 1996-01-30 | Bristol-Myers Squibb Company | Clear antiperspirant roll-on compositions |
US5545628A (en) * | 1995-01-10 | 1996-08-13 | Galephar P.R. Inc. | Pharmaceutical composition containing fenofibrate |
JPH08268878A (ja) * | 1995-03-06 | 1996-10-15 | Yoshiyuki Masui | 経口医薬品並びに加工食品 |
US5883103A (en) * | 1995-06-07 | 1999-03-16 | Shire Laboratories Inc. | Oral acyclovir delivery |
FR2761265B1 (fr) * | 1997-03-28 | 1999-07-02 | Sanofi Sa | Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates |
-
1998
- 1998-10-15 JP JP2000517694A patent/JP2001520984A/ja active Pending
- 1998-10-15 DE DE69811233T patent/DE69811233T2/de not_active Expired - Lifetime
- 1998-10-15 CN CNB988105934A patent/CN1190187C/zh not_active Expired - Fee Related
- 1998-10-15 WO PCT/EP1998/006544 patent/WO1999021534A1/en active IP Right Grant
- 1998-10-15 ES ES98955458T patent/ES2191977T3/es not_active Expired - Lifetime
- 1998-10-15 PT PT98955458T patent/PT996429E/pt unknown
- 1998-10-15 DK DK98955458T patent/DK0996429T3/da active
- 1998-10-15 EP EP98955458A patent/EP0996429B1/en not_active Expired - Lifetime
- 1998-10-15 AT AT98955458T patent/ATE232087T1/de active
-
2000
- 2000-04-26 NO NO20002133A patent/NO329755B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69811233D1 (de) | 2003-03-13 |
ATE232087T1 (de) | 2003-02-15 |
JP2001520984A (ja) | 2001-11-06 |
WO1999021534A1 (en) | 1999-05-06 |
NO20002133D0 (no) | 2000-04-26 |
DE69811233T2 (de) | 2003-11-20 |
EP0996429B1 (en) | 2003-02-05 |
DK0996429T3 (da) | 2003-05-26 |
EP0996429A1 (en) | 2000-05-03 |
CN1278164A (zh) | 2000-12-27 |
NO329755B1 (no) | 2010-12-13 |
PT996429E (pt) | 2003-06-30 |
NO20002133L (no) | 2000-04-26 |
CN1190187C (zh) | 2005-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2191977T3 (es) | Soluciones y dispersiones en estado solido de farmacos poco solubles en agua. | |
UY26977A1 (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgésicos | |
GT200000219A (es) | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco. | |
DE60142891D1 (de) | Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung | |
AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
AR028833A1 (es) | Compuestos inhibidores de metaloproteasas, composiciones farmaceuticas, uso para la manufactura de medicamentos, metodo de tratamiento y procedimiento para su preparacion | |
AR030609A1 (es) | Composicion catartica | |
CO5680109A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
PA8591701A1 (es) | Derivados de pirrolopirimidina | |
DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
BR0114799A (pt) | Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos | |
UY27368A1 (es) | Nuevos compuestos | |
SE0200979D0 (sv) | New compounds | |
ECSP034826A (es) | Método para fabricar una composición farmacéutica de dosis baja | |
ES2188426B1 (es) | Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias. | |
DK1638582T3 (da) | Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after | |
PT1109560E (pt) | Compostos uteis como inidores de aicarft | |
PA8525801A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
AR001769A1 (es) | Benzamida enterocinética composiciones farmacéuticas que las contienen procedimiento para la preparación de dichas composiciones farmacéuticas el uso de dichos compuestos para la manufactura de medicamentos y un procedimiento para su preparación | |
ATE308540T1 (de) | Antithrombosemittel | |
AR035064A1 (es) | 3-(1-metil-3-indolil)-4-(1-metil-6-nitro-3-indolil)-1h-pirrol-2,5-diona, en forma amorfa, procesos para prepararla, composicion farmaceutica que la comprende y uso de dicho compuesto en la fabricacion de medicamentos | |
AR021491A1 (es) | Un compuesto de 6-azauracilo que inhibe a il-5, una composicion que lo comprende, un proceso para preparar dicha composicion, y el uso de dicho compuestopara la manufactura de un medicamento y de un agente de diagnostico | |
UY26416A1 (es) | Compuestos | |
AR026451A1 (es) | Compuestos heterociclicos sililados | |
AR005730A1 (es) | Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato. |